Xiangyu Medical (688626.SH) Focuses on Non-Invasive Brain-Computer Interface Technology, Yet to Achieve Large-Scale Sales as of End-2025

Sunnyou (688626.SH) announced in a stock price fluctuation report that the capital market has recently shown high attention to concepts such as brain engineering and brain-computer interface, with significant increases in the share prices of related sectors. The company currently focuses on non-invasive brain-computer interface technology, covering a full range of rehabilitation scenarios including occupational therapy, physical therapy, cognitive speech, and swallowing. This approach differs from the current international invasive brain-computer interface technology routes. The company's investments in brain-computer interface have formed a certain layout in terms of technology, products, and market channels. However, due to the lag in bidding and sales, by the end of 2025, the relevant products have not yet achieved scaled sales, and their revenue contribution remains relatively small.